Related Experiment Video
Updated: Aug 5, 2025

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
HDL Function and Size in Patients with On-Target LDL Plasma Levels and a First-Onset ACS
Alberto Cordero1,2,3, Natàlia Muñoz-García4, Teresa Padró3,4
1Cardiology Department, Hospital Universitario de San Juan, 03550 Alicante, Spain.
Insights
This study reveals that for patients experiencing acute coronary syndrome (ACS) with normal lipid levels, impaired high-density lipoprotein (HDL) functionality and larger HDL particles are significant indicators. These findings highlight HDL functionality over concentration for assessing ACS risk.
Area of Science:
- Cardiovascular Medicine
- Lipidology
- Biochemistry
Background:
- Patients with acute coronary syndrome (ACS) often present with dyslipidemia, characterized by low high-density lipoprotein cholesterol (HDL-C) and high low-density lipoprotein cholesterol (LDL-C).
- Assessing cardiovascular risk in ACS patients with seemingly controlled lipid levels requires investigation into lipoprotein functionality and particle characteristics.
Purpose of the Study:
- To investigate the role of lipoprotein functionality, particle number, and size in first-onset ACS patients with on-target LDL-C levels.
- To compare lipoprotein characteristics between ACS patients and non-ACS individuals with similar lipid profiles.
Main Methods:
- Nuclear magnetic resonance (NMR) was used to assess HDL-C and LDL-C functionality, particle number, and size in 97 first-onset ACS patients and 31 healthy volunteers.
- Patients were categorized as ACS or non-ACS based on diagnostic tests including ECG, echocardiogram, troponin levels, and angiography.
- LDL susceptibility to oxidation and HDL antioxidant capacity were measured.
Main Results:
- ACS patients exhibited higher LDL susceptibility to oxidation and lower HDL antioxidant capacity compared to non-ACS individuals.
- Despite similar classical cardiovascular risk factors, ACS patients had lower HDL-C and Apolipoprotein A-I levels and impaired cholesterol efflux potential.
- ACS-ST-segment-elevation myocardial infarction (STEMI) patients showed significantly larger HDL particle diameter than non-ACS individuals.
Conclusions:
- Impaired lipoprotein functionality and larger HDL particles are observed in ACS patients even with on-target lipid levels.
- HDL functionality, rather than just HDL-C concentration, is a crucial factor in assessing cardiovascular risk in ACS patients.
- These findings suggest novel biomarkers for risk stratification in patients presenting with chest pain and first-onset ACS.
Abstract:
Patients admitted for acute coronary syndrome (ACS) usually have high cardiovascular risk scores with low levels of high-density lipoprotein cholesterol (HDL-C) and high low-density lipoprotein cholesterol (LDL-C) levels. Here, we investigated the role of lipoprotein functionality as well as particle number and size in patients with a first-onset ACS with on-target LDL-C levels. Ninety-seven patients with chest pain and first-onset ACS with LDL-C levels of 100 ± 4 mg/dL and non-HDL-C levels of 128 ± 4.0 mg/dL were included in the study. Patients were categorized as ACS and non-ACS after all diagnostic tests were performed (electrocardiogram, echocardiogram, troponin levels and angiography) on admission. HDL-C and LDL-C functionality and particle number/size by nuclear magnetic resonance (NMR) were blindly investigated. A group of matched healthy volunteers (n = 31) was included as a reference for these novel laboratory variables. LDL susceptibility to oxidation was higher and HDL-antioxidant capacity lower in the ACS patients than in the non-ACS individuals. ACS patients had lower HDL-C and Apolipoprotein A-I levels than non-ACS patients despite the same prevalence of classical cardiovascular risk factors. Cholesterol efflux potential was impaired only in the ACS patients. ACS-STEMI (Acute Coronary Syndrome-ST-segment-elevation myocardial infarction) patients, had a larger HDL particle diameter than non-ACS individuals (8.4 ± 0.02 vs. 8.3 ± 0.02 and, ANOVA test, p = 0.004). In conclusion, patients admitted for chest pain with a first-onset ACS and on-target lipid levels had impaired lipoprotein functionality and NMR measured larger HDL particles. This study shows the relevance of HDL functionality rather than HDL-C concentration in ACS patients.
More Related Videos
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Atherosclerosis I: Introduction